The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas

被引:5
|
作者
Alonso-Juarranz, Miguel [1 ,2 ]
Mascaraque, Marta [3 ,4 ]
Carrasco, Elisa [3 ,5 ]
Gracia-Cazana, Tamara [6 ]
De La Sen, Oscar [1 ,2 ]
Gilaberte, Yolanda [6 ]
Gonzalez, Salvador [5 ,7 ]
Juarranz, Angeles [3 ,5 ]
Falahat, Farzin [1 ,2 ]
机构
[1] Hosp Clin San Carlos, Oral & Maxillofacial Surg Serv, Madrid 28040, Spain
[2] Univ Complutense, Fac Med, Surg Dept, Madrid 28040, Spain
[3] Univ Autonoma Madrid, Dept Biol, Madrid 28049, Spain
[4] Miguel Servet Univ Hosp, Translat Res Unit, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[5] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Dept Expt Dermatol & Skin Biol, Madrid 28034, Spain
[6] Miguel Servet Univ Hosp, Dept Dermatol, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[7] Univ Alcala, Dept Med & Med Specialties, Madrid 28871, Spain
关键词
oral squamous cell carcinoma; cutaneous squamous cell carcinoma; tumor microenvironment; cancer-associated fibroblasts; immune cells; tertiary lymphoid structures; EPITHELIAL-MESENCHYMAL TRANSITION; GENOMIC CHARACTERIZATION; FIBROBLAST ACTIVATION; CANCER; HEAD; RISK; PROGRESSION; INVASION; THERAPY; MACROPHAGES;
D O I
10.3390/cancers15123227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In this review, we describe the recent studies that define the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively). Mutations in tumor suppressor genes and protooncogenes cooperate in determining the differentiation, aggressiveness, and metastatic potential of these types of cancers. Driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. We also describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes have been more frequently reported as predictors of good responses in OSCC than CSCC. Squamous cell carcinomas arise from stratified squamous epithelia. Here, a comparative analysis based on recent studies defining the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively) was performed. Both carcinomas share some but not all histological and genetic features. This review was focused on how mutations in tumor suppressor genes and protooncogenes cooperate to determine the differentiation, aggressiveness, and metastatic potential of OSCC and CSCC. In fact, driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. These include mutations in TP53 (encoding pP53 protein), CDKN2A (encoding cyclin dependent kinase inhibitor 2A), FAT1 (encoding FAT atypical cadherin 1), and KMT2D (encoding lysine methyltransferase 2D), with the exception of NOTCH (encoding Notch receptor 1), whose mutation frequency is lower in OSCC compared to CSCC. Finally, we describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes (TILs) have been more frequently reported as predictors of better outcomes in OSCC than CSCC. In conclusion, OSCC and CSCC partially share genetic alterations and possess different causal factors triggering their development. The tumor microenvironment plays a key role determining the outcome of the disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas
    Banerjee, Sagarika
    Tian, Tian
    Wei, Zhi
    Peck, Kristen N.
    Shih, Natalie
    Chalian, Ara A.
    O'Malley, Bert W.
    Weinstein, Gregory S.
    Feldman, Michael D.
    Alwine, James
    Robertson, Erle S.
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Cutaneous and lip squamous cell carcinomas in an albinism patient: A case report
    Siauta, Jan Frits
    Windura, Carolus Aldo
    Putra, Louis Kartono
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [43] Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas
    Morais, Everton Freitas de
    Almangush, Alhadi
    Salo, Tuula
    da Silva, Sabrina Daniela
    Kujan, Omar
    Coletta, Ricardo D.
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (01) : 1 - 12
  • [44] Genetic polymorphisms and HPV infection in oral squamous cell carcinomas
    Sun, Yan
    Zhang, Yang
    Liu, Limei
    Song, Xicheng
    Li, Guojun
    CURRENT OPINION IN VIROLOGY, 2015, 14 : 1 - 6
  • [45] Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment
    Firnhaber, Jonathon M.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (06) : 339 - 346
  • [46] Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas
    El-Rouby, Dalia H.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2010, 39 (07) : 559 - 564
  • [47] Persistent activation of the mammalian target of rapamycin signalling pathway in cutaneous squamous cell carcinomas in cats
    Sanz Ressel, Berenice L.
    Massone, Adriana R.
    Barbeito, Claudio G.
    VETERINARY DERMATOLOGY, 2021, 32 (06) : 675 - +
  • [48] Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan
    Peng, Hsin-Hui
    Ko, Hui-Hsin
    Chi, Nai-Chi
    Wang, Yi-Ping
    Lee, Hsiang-Chieh
    Pan, Pei-Yao
    Kuo, Mark Yen-Ping
    Cheng, Shih-Jung
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (01): : 5 - 13
  • [49] Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma
    Wu, Cong-Cong
    Xiao, Yao
    Li, Hao
    Mao, Liang
    Deng, Wei-Wei
    Yu, Guang-Tao
    Zhang, Wen-Feng
    Sun, Zhi-Jun
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (04) : 772 - 778
  • [50] Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study
    Lajer, C. B.
    Nielsen, F. C.
    Friis-Hansen, L.
    Norrild, B.
    Borup, R.
    Garnaes, E.
    Rossing, M.
    Specht, L.
    Therkildsen, M. H.
    Nauntofte, B.
    Dabelsteen, S.
    von Buchwald, C.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 830 - 840